Animal models for Niemann-Pick type C: implications for drug discovery & development.

Authors:
Cathrine K Fog
Cathrine K Fog
University of Copenhagen
Thomas Kirkegaard
Thomas Kirkegaard
Institute of Cancer Biology
Denmark

Expert Opin Drug Discov 2019 May 19;14(5):499-509. Epub 2019 Mar 19.

a Orphazyme A/S , Copenhagen , Denmark.

Introduction: Niemann-Pick type C (NPC) is a neurovisceral, progressively detrimental lysosomal storage disease with very limited therapeutic options and no approved treatment available in the US. Despite its rarity, NPC has seen increased drug developmental efforts over the past decade, culminating in the completion of two potential registration trials in 2018. Areas covered: This review highlights the many available animal models that have been developed in the field and briefly covers classical and new cell technologies. This review provides a high-level evaluation and prioritization of the various models with regard to efficient and clinically translatable drug development, and briefly discusses the relevant developments and opportunities pertaining to this. Expert opinion: With a number of in vitro and in vivo models available, and with having several drugs, all with various mechanisms of action, either approved or in late stage development, the NPC field is in an exciting time. One of the challenges for researchers and developers will be the ability to make use of the lessons learnt from existing late-stage programs as well as the incorporation not only of the opportunities but also the limitations of the many models into successful drug discovery and translational development programs.

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2019.1588882DOI Listing
May 2019
2 Reads

Publication Analysis

Top Keywords

drug discovery
8
niemann-pick type
8
animal models
8
covers classical
4
classical cell
4
researchers developers
4
developed field
4
field covers
4
challenges researchers
4
technologies review
4
time challenges
4
evaluation prioritization
4
high-level evaluation
4
review high-level
4
models developed
4
cell technologies
4
highlights animal
4
drugs mechanisms
4
trials 2018
4
registration trials
4

References

(Supplied by CrossRef)
Article in Neurol Clin Pract
Patterson MC et al.
Neurol Clin Pract 2017
Article in J Lipid Res
Pipalia NH et al.
J Lipid Res 2017

Similar Publications